Study of a Flu Vaccine in Children
NCT00001127 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 15000
Last updated 2010-08-27
Summary
This study tests the safety and effectiveness of a flu vaccine in school children.
School children are usually the first members of a community to come down with the flu, and they often give the flu to their younger siblings, parents, and grandparents. It is hoped that giving school children a flu vaccine can help prevent the spread of the flu to other members of the community.
Conditions
Interventions
- BIOLOGICAL
-
Influenza virus vaccine (CAIV-T)
Sponsors & Collaborators
-
Aviron LLC
collaborator INDUSTRY -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Study Design
- Purpose
- PREVENTION
- Masking
- NONE
Eligibility
- Min Age
- 18 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Completion
- 2005-11-30
Countries
- United States
Study Locations
More Related Trials
-
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers
NCT00192283 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children
NCT00192270 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Quadrivalent Influenza Vaccine Among Children
NCT01240746 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment
NCT00138385 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
NCT02212106 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children
NCT00192244 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)
NCT00192361 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.
NCT00192179 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents
NCT02387294 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age
NCT01857206 ·Status: COMPLETED ·Phase: PHASE3
-
Immunologic Response to Influenza Vaccination in Children and Adolescents
NCT03614975 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
NCT00091702 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Influenza Immunization of Children in India
NCT01680679 ·Status: COMPLETED ·Phase: PHASE4
-
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
NCT00138294 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children
NCT00391391 ·Status: COMPLETED ·Phase: PHASE2
-
Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents
NCT00645411 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools
NCT01995851 ·Status: COMPLETED
-
Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
NCT00192166 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.
NCT00192400 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.
NCT01964989 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children
NCT00192374 ·Status: COMPLETED ·Phase: PHASE3
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Sanofi Pasteur, TIV + H1N1, Pediatric Population
NCT00943202 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children
NCT00192322 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist
NCT00231907 ·Status: COMPLETED ·Phase: PHASE1